Navigation Links
Researchers discover the mechanism that determines cell position in the intestinal epithelium

How do cells know where to position themselves and where to accumulate in order to carry out their functions correctly within each organ? Researchers with the Colorectal Cancer Lab at IRB Barcelona have revealed the molecular mechanisms responsible for organizing the intestinal epithelium into distinct comportments, defined by frontiers or territories. The study, headed by Eduard Batlle, coordinator of the Oncology Programme at IRB Barcelona and ICREA Research Professor, is published in today's online version of the Journal Nature Cell Biology, part of the prestigious editorial group Nature.

The organization of tissues and organs in the human body can be compared to a very complex and sophisticated engine, whose structure is maintained by positioning its components (cells) in a very precise way. Errors in the assembly (location) of the components might lead to changes in the function of the engine (tissue or organ).

New protein complexes that position cells in the right place

Complex tissues and organs require the separation of diverse cells types into separate zones in order to maintain their architecture. In the case of the intestinal epithelium, the lower part of the invaginations formed by the epithelium, called crypts, contains stem cells that regenerate tissue, while the upper part holds differentiated cells that are responsible for nutrient absorption.

The so-called EphB receptors, present in the cells at the bottom of the crypts, bind to Ephrin ligands located mainly in differentiated cells in the upper part of the intestinal epithelium. The ligand-receptor binding occurs at the frontier between the two cell populations and controls cell positioning in the tissue. However, until now, the way in which these ligand-receptor bindings instruct cells to position themselves in one place or another was unknown.

The results of this study demonstrate that EphB-ephrin bindings activate the metaloprotease ADAM10, which destroys the binding between distinct cell types, such as between cells from the bottom and surface of crypts. It is the destruction of these binding between cells from distinct compartments that prevents cell mixing, thus impeding once cell type from entering the wrong territory. In the words of Guiomar Solanas, first author of the article, "we have found the molecular mechanisms by which EphB receptors and their ligands tell each cell where it has to be throughout its life: from its generation from stem cells in the crypt bottom until its differentiation".

The loss of cell organization in a tissue is often associated with cancer. In addition to the loss of EphB receptor function in tumors is associated with a worse prognosis for patients. This new regulatory mechanism of affinity between cells types and territory maintenance could be key to our understanding of how less aggressive tumors evolve into malignant ones.


Contact: Nuria Noriega
Institute for Research in Biomedicine (IRB Barcelona)

Related biology news :

1. NC State researchers get to root of parasite genome
2. Researchers find animal with ability to survive climate change
3. Researchers find an essential gene for forming ears of corn
4. Researchers note differences between people and animals on calorie restriction
5. Researchers study acoustic communication in deep-sea fish
6. Researchers discover that growing up too fast may mean dying young in honey bees
7. Researchers study how pistachios may improve heart health
8. UI researchers find potentially toxic substance present in Chicago air
9. Researchers develop new self-training gene prediction program for fungi
10. Case Western Reserve University researchers track Chernobyl fallout
11. Childrens National researchers develop novel anti-tumor vaccine
Post Your Comments:
(Date:5/12/2016)... 2016 , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle ... people with peritoneal or pleural mesothelioma. Their findings are the subject of a new ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... announce the launch of their brand, UP4™ Probiotics, into Target stores nationwide. The ... is proud to add Target to its list of well-respected retailers. This list ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
Breaking Biology Technology: